DEA Directs Agencies on the Legality of Hemp-Derived Cannabinoids

Screen Shot 2017 09 08 at 1.18.15 PM
Screen Shot 2017 09 08 at 1.18.15 PM

Denver, CO – In an unexpected move, Hoban Law Group has negotiated with the DEA on new policy for hemp-derived cannabinoids. Attorneys Patrick Goggin and Garrett Graff have issued the following article for explanation.

In 2004, the Ninth Circuit Court of Appeals, in its seminal HIA v. DEA II opinion, struck down a DEA rule that would have banned the human consumption of lawful non-psychoactive hemp (i.e. stalks and sterilized seed) because of the presence of naturally occurring THC, the primary psychoactive compound associated with marijuana. Despite the presence of naturally occurring THC, the Court found that “Congress knew what it was doing, and its intent to exclude non-psychoactive hemp from regulation is entirely clear.” (continued)

Advertisement
Greenbroz - Leaderboard

Advertisement
polyscience.com